Benjamin Eric

EVP Benjamin Eric sold 4,263 shares of PODD at $332.23 on 2025-08-21 under 10b5-1 plan; post-sale holdings: 16,736 shares

Benjamin Eric, EVP of CPXO, sold 4,263 shares of Insulet Corp (PODD) for a total value of $1,416,296.49 as part of a pre-arranged 10b5-1 trading plan, reducing his holdings by 20.3% to 16,736 shares. Since this transaction was scheduled under a Rule 10b5-1 plan rather than discretionary, it reflects a predetermined execution rather than a timing decision by the executive. The sale represents a significant proportional reduction in his position but does not provide evidence of a sudden change in conviction given the systematic nature of the plan.

EVP Benjamin Eric sold 12,394 shares of PODD at $280.00 (-52.1% of holdings) for $3,470,320.00

Benjamin Eric, EVP at INSULET CORP (PODD), sold 12,394 shares at $280.00 on 2025-01-21, reducing his holdings from 23,777 shares to 11,383 shares (a -52.1% reduction). The sale occurred at the company's 52-week high of $278.89, coinciding with strong recent momentum: the stock is up 5.9% over 30 days and 17.4% over 90 days. The company shows solid fundamentals with annual revenue growth of +30.0% and a P/E of 46.48, though the valuation reflects elevated expectations typical of growth-oriented medical device manufacturers. His prior sell at this ticker on 2024-12-16 generated a -1.2% return over 30 days, providing limited historical context for this ticker's sell-timing patterns.

EVP Benjamin Eric sold 4,362 shares of PODD at $267.60 for $1.2M, reducing holdings by 18.9% to 18,702 shares

Benjamin Eric sold 4,362 shares (4.4K shares) at $267.60, representing a substantial 18.9% reduction in his PODD holdings from 23,064 shares to 18,702 shares. The sale occurred near the 52-week high of $275.70, with the stock currently at $263.35. INSULET is trading at a P/E of 43.89 with strong fundamentals: $543.9M in latest quarterly revenue and $77.5M net income, supported by 30.0% annual revenue growth. The magnitude of the reduction and the proximity to recent highs merit investor attention in the context of the company's elevated valuation multiple.